QuidelOrtho (QDEL) director John R. Chiminski receives new RSU board grants

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

QuidelOrtho Corp director John R. Chiminski reported awards of restricted stock units (RSUs) linked to common stock. On June 25, 2026, he acquired 1,109 premium RSUs, 5,547 converted RSUs, and 15,532 equity grant RSUs as compensation.

Each RSU represents one share of QuidelOrtho common stock and carries a grant price of $0.00 per unit. One set of RSUs will vest on June 25, 2027, while an additional 1,386 units vested on June 25, 2026 and 1,387 units are scheduled to vest on each of September 25, 2026, December 25, 2026 and March 25, 2027. The RSUs were received in lieu of cash fees under a deferred compensation program for non‑employee directors, with release of vested units following the director’s elected deferral schedule.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Chiminski John R

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (Equity Grant)	15,532	$0.00	--
Grant/Award	Restricted Stock Units (Converted)	5,547	$0.00	--
Grant/Award	Restricted Stock Units (Premium)	1,109	$0.00	--

Holdings After Transaction: Restricted Stock Units (Equity Grant) — 15,532 shares (Direct, null); Restricted Stock Units (Converted) — 5,547 shares (Direct, null); Restricted Stock Units (Premium) — 1,109 shares (Direct, null)

Footnotes (1)

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. The restricted stock units will vest on June 25, 2027. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.

Key Figures

Premium RSU grant: 1,109 units Converted RSU grant: 5,547 units Equity grant RSUs: 15,532 units +3 more

6 metrics

Premium RSU grant 1,109 units Restricted Stock Units (Premium) granted on June 25, 2026

Converted RSU grant 5,547 units Restricted Stock Units (Converted) granted on June 25, 2026

Equity grant RSUs 15,532 units Restricted Stock Units (Equity Grant) granted on June 25, 2026

Vested tranche 1,386 units RSUs vested on June 25, 2026

Future vesting tranches 1,387 units each Vest on Sept 25, 2026; Dec 25, 2026; Mar 25, 2027

Vesting date for one grant June 25, 2027 Restricted stock units scheduled to vest on this date

Key Terms

Restricted Stock Units, deferred compensation program, vest, retainer and Board of Director service-related fees

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

deferred compensation program financial

"under a deferred compensation program applicable to participating non-employee directors."

vest financial

"The restricted stock units will vest on June 25, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/29/2026 - 06:00 PM Accepted by SEC EDGAR 06/29/2026 - 06:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chiminski John R

(Last)

(First)

(Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO

CALIFORNIA

92121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (Equity Grant)	⁽¹⁾	06/25/2026		A		15,532		⁽²⁾	⁽²⁾	Common Stock	15,532	$0	15,532	D
Restricted Stock Units (Converted)	⁽¹⁾	06/25/2026		A		5,547		⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	Common Stock	5,547	$0	5,547	D
Restricted Stock Units (Premium)	⁽¹⁾	06/25/2026		A		1,109		⁽²⁾⁽³⁾	⁽²⁾⁽³⁾	Common Stock	1,109	$0	1,109	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

2. The restricted stock units will vest on June 25, 2027.

3. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.

4. 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.

Remarks:

	/s/ Euna Greene, attorney-in-fact for John R. Chiminski	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did QuidelOrtho (QDEL) director John R. Chiminski report on this Form 4?

He reported awards of restricted stock units as non-cash board compensation. On June 25, 2026, he received three RSU grants tied to QuidelOrtho common stock, all at a grant price of $0.00 per unit under a deferred compensation program.

How many restricted stock units did John R. Chiminski receive from QuidelOrtho (QDEL)?

He received 1,109 premium RSUs, 5,547 converted RSUs, and 15,532 equity grant RSUs. Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock upon vesting and release under his elected deferral schedule.

When do John R. Chiminski’s QuidelOrtho (QDEL) restricted stock units vest?

One grant of restricted stock units will vest on June 25, 2027. Separately, 1,386 units vested June 25, 2026, and 1,387 units are scheduled to vest on September 25, 2026, December 25, 2026, and March 25, 2027, respectively.

How are QuidelOrtho (QDEL) board fees being paid to John R. Chiminski in this filing?

Board fees are being paid in restricted stock units instead of cash. The RSUs were received in lieu of certain retainer and Board service-related cash payments under a deferred compensation program for participating non-employee directors.

What does each QuidelOrtho (QDEL) restricted stock unit represent for John R. Chiminski?

Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. Delivery of those shares occurs after the RSUs vest and are released according to Chiminski’s elected deferral schedule under the company’s deferred compensation program.